Skip to main content
NCBI home page
Heart logoLink to Heart
. 1998 Mar;79(3):253–255. doi: 10.1136/hrt.79.3.253

Subpectoral implantation of a cardioverter defibrillator under local anaesthesia

K Lipscomb 1, N Linker 1, A Fitzpatrick 1
PMCID: PMC1728644  PMID: 9602658

Abstract

Objective—To evaluate patient acceptability of submuscular implantation of a cardioverter defibrillator (ICD) under local anaesthesia with conscious sedation.
Design—Retrospective review. Patient acceptability in the second half of the study was routinely assessed within 24 hours. 
Setting—Regional cardiac centre.
Patients—45 consecutive patients with either aborted sudden death or haemodynamically unstable ventricular tachycardia were referred for ICD im- plantation.
Interventions—A subpectoral implantation technique was employed. Twelve procedures were performed under general anaesthesia. Thirty three patients were sedated with midazolam and diamorphine, and local anaesthesia was achieved with bupivicaine. Ventricular fibrillation for defibrillation threshold testing was induced by alternating current, T wave shock, or ultrarapid burst pacing. Patients were contacted after the procedure to assess acceptability.
Results—32 patients having implantation under local anaesthesia did not recall the surgical procedure. One patient described an awareness of "pushing" as the generator was positioned in the pocket. Seven patients said that the procedure was painless but recalled a test shock, four describing it as mildly uncomfortable. All 33 patients stated that they would be willing to have a second implant under local anaesthesia. Twelve patients who had the implant performed under general anaesthesia had no recollection of the procedure. Mean (SD) total procedure duration was significantly longer in those who had general anaesthesia (93 (16) v 67 (17) minutes; p = 0.0009).
Conclusions—Subpectoral implantation of ICDs may be performed safely with patient acceptability under local anaesthesia with conscious sedation.

 Keywords: cardioverter defibrillator;  subpectoral implantation;  local anaesthesia;  pacing

Full Text

The Full Text of this article is available as a PDF (63.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardy G. H., Hofer B., Johnson G., Kudenchuk P. J., Poole J. E., Dolack G. L., Gleva M., Mitchell R., Kelso D. Implantable transvenous cardioverter-defibrillators. Circulation. 1993 Apr;87(4):1152–1168. doi: 10.1161/01.cir.87.4.1152. [DOI] [PubMed] [Google Scholar]
  2. Chuang E., Wenner W. J., Jr, Piccoli D. A., Altschuler S. M., Liacouras C. A. Intravenous sedation in pediatric upper gastrointestinal endoscopy. Gastrointest Endosc. 1995 Aug;42(2):156–160. doi: 10.1016/s0016-5107(95)70073-0. [DOI] [PubMed] [Google Scholar]
  3. Eastman D. P., Selle J. G., Reames M. K., Sr Technique for subpectoral implantation of cardioverter defibrillators. J Am Coll Surg. 1995 Nov;181(5):475–476. [PubMed] [Google Scholar]
  4. Ehrle U. B., Horschler B., Singer M. V. Akzeptanz der hohen Koloskopie bei unterschiedlicher Prämedikation--ein Vergleich der Wirkung von Midazolam versus Midazolam und Pethidin von seiten des Patienten und des Arztes. Z Gastroenterol. 1995 Dec;33(12):704–708. [PubMed] [Google Scholar]
  5. Foster A. H. Technique for implantation of cardioverter defibrillators in the subpectoral position. Ann Thorac Surg. 1995 Mar;59(3):764–767. doi: 10.1016/0003-4975(94)00960-0. [DOI] [PubMed] [Google Scholar]
  6. Gold M. R., Foster A. H., Shorofsky S. R. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol. 1996 Sep 1;78(5):540–543. doi: 10.1016/s0002-9149(96)00361-x. [DOI] [PubMed] [Google Scholar]
  7. Gold M. R., Peters R. W., Johnson J. W., Shorofsky S. R. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators. J Am Coll Cardiol. 1996 Nov 1;28(5):1278–1282. doi: 10.1016/s0735-1097(96)00314-2. [DOI] [PubMed] [Google Scholar]
  8. Graff K. J., Kennedy R. M., Jaffe D. M. Conscious sedation for pediatric orthopaedic emergencies. Pediatr Emerg Care. 1996 Feb;12(1):31–35. doi: 10.1097/00006565-199602000-00009. [DOI] [PubMed] [Google Scholar]
  9. Grogler F. M., Frank G., Greven G., Dragojevic D., Oelert H., Leitz K., Dalichau H., Brinke U., Lohlein D., Rogge D. Complications of permanent transvenous cardiac pacing. J Thorac Cardiovasc Surg. 1975 Jun;69(6):895–904. [PubMed] [Google Scholar]
  10. Gross J. B., Blouin R. T., Zandsberg S., Conard P. F., Häussler J. Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil. Anesthesiology. 1996 Oct;85(4):713–720. doi: 10.1097/00000542-199610000-00005. [DOI] [PubMed] [Google Scholar]
  11. Hammel D., Block M., Geiger A., Böcker D., Stadlbauer T., Breithardt G., Scheld H. H. Single-incision implantation of cardioverter defibrillators using nonthoracotomy lead systems. Ann Thorac Surg. 1994 Dec;58(6):1614–1616. doi: 10.1016/0003-4975(94)91644-6. [DOI] [PubMed] [Google Scholar]
  12. Hosking D. H., Bard R. J. Ureteroscopy with intravenous sedation for treatment of distal ureteral calculi: a safe and effective alternative to shock wave lithotripsy. J Urol. 1996 Sep;156(3):899–902. [PubMed] [Google Scholar]
  13. Jacobs D. M., Fink A. S., Miller R. P., Anderson W. R., McVenes R. D., Lessar J. F., Cobian K. E., Staffanson D. B., Upton J. E., Bubrick M. P. Anatomical and morphological evaluation of pacemaker lead compression. Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 1):434–444. doi: 10.1111/j.1540-8159.1993.tb01606.x. [DOI] [PubMed] [Google Scholar]
  14. Lawton J. S., Wood M. A., Gilligan D. M., Stambler B. S., Damiano R. J., Jr, Ellenbogen K. A. Implantable transvenous cardioverter defibrillator leads: the dark side. Pacing Clin Electrophysiol. 1996 Sep;19(9):1273–1278. doi: 10.1111/j.1540-8159.1996.tb04204.x. [DOI] [PubMed] [Google Scholar]
  15. Magney J. E., Flynn D. M., Parsons J. A., Staplin D. H., Chin-Purcell M. V., Milstein S., Hunter D. W. Anatomical mechanisms explaining damage to pacemaker leads, defibrillator leads, and failure of central venous catheters adjacent to the sternoclavicular joint. Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 1):445–457. doi: 10.1111/j.1540-8159.1993.tb01607.x. [DOI] [PubMed] [Google Scholar]
  16. Markewitz A., Kaulbach H., Mattke S., Dorwarth U., Weinhold C., Hoffmann E., Steinbeck G., Reichart B. One-incision approach for insertion of implantable cardioverter defibrillators. Ann Thorac Surg. 1994 Dec;58(6):1609–1613. doi: 10.1016/0003-4975(94)91643-8. [DOI] [PubMed] [Google Scholar]
  17. McCloy R. F. Reversal of conscious sedation by flumazenil: current status and future prospects. Acta Anaesthesiol Scand Suppl. 1995;108:35–42. [PubMed] [Google Scholar]
  18. Milgrom P., Beirne O. R., Fiset L., Weinstein P., Tay K. M., Martin M. The safety and efficacy of outpatient midazolam intravenous sedation for oral surgery with and without fentanyl. Anesth Prog. 1993;40(3):57–62. [PMC free article] [PubMed] [Google Scholar]
  19. Pfeiffer D., Jung W., Fehske W., Korte T., Manz M., Moosdorf R., Lüderitz B. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J. 1994 Apr;127(4 Pt 2):1073–1080. doi: 10.1016/0002-8703(94)90090-6. [DOI] [PubMed] [Google Scholar]
  20. Rembacken B. J., Axon A. T. The role of pethidine in sedation for colonoscopy. Endoscopy. 1995 Mar;27(3):244–247. doi: 10.1055/s-2007-1005679. [DOI] [PubMed] [Google Scholar]
  21. Roelke M., O'Nunain S. S., Osswald S., Garan H., Harthorne J. W., Ruskin J. N. Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol. 1995 May;18(5 Pt 1):973–979. doi: 10.1111/j.1540-8159.1995.tb04737.x. [DOI] [PubMed] [Google Scholar]
  22. Stanton M. S., Hayes D. L., Munger T. M., Trusty J. M., Espinosa R. E., Shen W. K., Osborn M. J., Packer D. L., Hammill S. C. Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc. 1994 Apr;69(4):309–314. doi: 10.1016/s0025-6196(12)62213-7. [DOI] [PubMed] [Google Scholar]
  23. Strickberger S. A., Hummel J. D., Daoud E., Niebauer M., Williamson B. D., Man K. C., Horwood L., Schmittou A., Kalbfleisch S. J., Langberg J. J. Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation. 1994 Aug;90(2):868–872. doi: 10.1161/01.cir.90.2.868. [DOI] [PubMed] [Google Scholar]
  24. Strickberger S. A., Niebauer M., Man K. C., Daoud E., Williamson B. D., Horwood L., Hummel J. D., Morady F. Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory. Am J Cardiol. 1995 Feb 1;75(4):255–257. doi: 10.1016/0002-9149(95)80031-m. [DOI] [PubMed] [Google Scholar]
  25. Tung R. T., Bajaj A. K. Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory. Am J Cardiol. 1995 May 1;75(14):908–912. doi: 10.1016/s0002-9149(99)80685-7. [DOI] [PubMed] [Google Scholar]
  26. Venditti F. J., Jr, O'Connell M., Martin D. T., Shahian D. M. Transvenous cardioverter defibrillators: cost implications of a less invasive approach. Pacing Clin Electrophysiol. 1995 Apr;18(4 Pt 1):711–715. doi: 10.1111/j.1540-8159.1995.tb04665.x. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES